Sneezing, fever, chills, vomiting, coughing — it’s not just one virus wreaking havoc this winter; it’s a combination of four major illnesses: influenza, respiratory syncytial virus (RSV), COVID 19 and norovirus. In the United States, some health experts are referring to the simultaneous spread of these four viruses as a “quademic.” But is the same spread happening in Canada?…
In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds. While many of the germs that cause this misery can circulate throughout the year, scientists think that the winter surge of flu and cold activity may be because we spend more time indoors and the cold, dry air may…
As the respiratory illness season begins, cases of respiratory syncytial virus (RSV) cases are rising in Canada. But a new tool — nirsevimab, a protective antibody for infants — offers hope for prevention, though it is currently available only in some provinces. The latest data from Health Canada, covering the week of Nov. 24 to Nov….
Descrease article font size Increase article font size Moderna said on Friday that Canada’s health regulator has approved its vaccine for respiratory syncytial virus (RSV) in adults 60 years and older, making it the country’s first authorized mRNA-based shot for the condition. Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory…
